Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Masterflex: „Ein echter Meilenstein“ (4investors) +++ MASTERFLEX Aktie +3,75%

TANDEM DIABETES Aktie

 >TANDEM DIABETES Aktienkurs 
17.4475 EUR    (Tradegate)
Ask: 17.575 EUR / 428 Stück
Bid: 17.32 EUR / 435 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
Aktie über LYNX handeln
>TANDEM DIABETES Performance
1 Woche: -3,6%
1 Monat: -3,8%
3 Monate: -7,1%
6 Monate: -50,4%
1 Jahr: -56,5%
laufendes Jahr: -50,4%
>TANDEM DIABETES Aktie
Name:  TANDEM DIABETES NEW -,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US8753722037 / A2H5BX
Symbol/ Ticker:  TD5A (Frankfurt) / TNDM (NASDAQ)
Kürzel:  FRA:TD5A, ETR:TD5A, TD5A:GR, NASDAQ:TNDM
Index:  -
Webseite:  https://www.tandemdiabete..
Marktkapitalisierung:  1190 Mio. EUR
Umsatz:  852.04 Mio. EUR
EBITDA:  -65.07 Mio. EUR
Gewinn je Aktie:  -2.089 EUR
Schulden:  431.76 Mio. EUR
Liquide Mittel:  319.53 Mio. EUR
Umsatz-/ Gewinnwachstum:  22.3% / -
KGV/ KGV lG:  - / 1000
KUV/ KBV/ PEG:  1.39 / 8.9 / -
Gewinnm./ Eigenkapitalr.:  -18.71% / -92.31%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  TANDEM DIABETES
Letzte Datenerhebung:  24.06.25
>Eigentümer
Aktien: 66.61 Mio. St.
f.h. Aktien: 61.46 Mio. St.
Insider Eigner: 0.94%
Instit. Eigner: 111.67%
>Peer Group

 
23.06.25 - 17:30
TNDM Stock Gains on t:slim X2′s Compatibility With FreeStyle Libre 3 + (Zacks)
 
Tandem Diabetes' t:slim X2 pump with Control-IQ+ tech gains U.S. early access using FreeStyle Libre 3 Plus sensor....
24.05.25 - 00:06
Tandem Diabetes To Pay Roche $36 Mln To Settle Patent Infringement Claim (AFX)
 
SOUTH SAN FRANCISCO (dpa-AFX) - Tandem Diabetes Care, Inc. has agreed to pay Roche Holding $36 million over a five year period to settle a patent infringement claim.On May 21, Tandem Diabetes Care......
22.05.25 - 14:30
Should Tandem Diabetes Stock Stay in Your Portfolio Now? (Zacks)
 
Investors remain optimistic about TNDM, courtesy of its strong t:slim X2 performance and breakthrough innovations....
02.05.25 - 16:00
TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up (Zacks)
 
Tandem Diabetes' Q1 bottom line lags estimate. However, the company experiences strong sales growth both in and outside the United States....
01.05.25 - 21:30
Tandem Diabetes jumps as overseas sales drive Q1 beat (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
01.05.25 - 02:30
Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
 
Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....
01.05.25 - 02:15
Tandem Diabetes Care highlights potential for type 2 diabetes market growth with Control-IQ+ (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.04.25 - 22:42
Tandem Diabetes Care GAAP EPS of -$1.97 misses by $1.35, revenue of $234.4M beats by $14.18M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.04.25 - 22:09
Tandem Diabetes Care Announces First Quarter 2025 Financial Results (Business Wire)
 
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2025. First Quarter 2025 Highlights, Financial Results Compared to First Quarter 2024 Achieved record first quarter sales with worldwide growth of 22% Increased pump sales in the United States by 19% on a GAAP basis and 17% on a non-GAAP(1) basis, on strong shipment growth and average selling price improvement Delivered 5 point adjusted EBITDA(1) margin increase Approximately 30% of U.S. lives now covered through pharmacy benefits for Tandem Mobi Benefits of Control-IQ Technology were featured for a fourth time in The New England Journal of Medicine “The strength of our first quarter performance was driven by more than 20% worldwide sales growth, including our highest quarter ever outside the United States,” said John Sheridan, president and chief executive officer. “We are creating new possibilities for...
29.04.25 - 23:24
Tandem Diabetes Care Q1 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
03.04.25 - 22:09
Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025 (Business Wire)
 
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2025 results after the financial markets close on Wednesday, April 30, 2025. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2025 financial and operating results. A live webcast of the call will be available on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section. To access the call by phone, please use this link (https://register-conf.media-server.com/register/BI72222fa42d1c492fb004c1b47dbaf791) and you will be provided with dial-in details, including a personal pin. An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the “Eve...
28.03.25 - 18:00
Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound? (Zacks)
 
Tandem Diabetes Care (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
19.03.25 - 15:45
TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology (Zacks)
 
Tandem Diabetes launches Control-IQ+ technology commercially in the United States. Control-IQ+ is compatible with t:slim X2 insulin pump and Tandem Mobi System....
12.03.25 - 00:01
Insiderhandel: EVP & Chief Operating Officer kauft Aktien von Tandem Diabetes Care im Wert von 190966 USD (Insiderkauf)
 
Kyrillos, Jean-Claude - Vorstand - Tag der Transaktion: 2025-03-07...
11.03.25 - 15:00
Reasons to Hold TNDM Stock in Your Portfolio for Now (Zacks)
 
A robust product innovation and several strategic developments raise investors' optimism for Tandem Diabetes....
05.03.25 - 15:36
Tandem Diabetes Care downgraded to Equal-weight on guidance concerns (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
03.03.25 - 19:15
Bernstein downgrades Tandem Diabetes on market share loss concerns (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
27.02.25 - 20:51
The Analyst Verdict: Tandem Diabetes Care In The Eyes Of 4 Experts (Benzinga)
 
Latest Ratings for TNDM DateFirmActionFromTo Feb 2022Wells FargoMaintainsOverweight Feb 2022CitigroupMaintainsBuy Feb 2022SVB LeerinkMaintainsMarket Perform View More Analyst Ratings for TNDM View the Latest Analyst Ratings read more...
27.02.25 - 16:00
TNDM Stock Falls in Aftermarket Following Q4 Earnings and Revenue Miss (Zacks)
 
Tandem Diabetes' Q4 top and bottom lines lag their respective estimate. However, the company experiences strong sales growth both in and outside the United States....
27.02.25 - 02:30
Here′s What Key Metrics Tell Us About Tandem Diabetes Care (TNDM) Q4 Earnings (Zacks)
 
While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Was man zu lang bedenkt, das wird bedenklich. - Sprichwort
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!